| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |